University of Manchester

Clerkenwell Health is collaborating with researchers at the University of Manchester to run Phase II studies. Trials here aim to assess the impact of talking therapy informed by Perceptual Control Theory alongside different doses of psilocybin, led by Dr Sara Tai who has previously been involved with Compass Pathways.